Judith S. Currier MD, MSc, MPH

Judith S. Currier, MD, MSc, is Associate Director of the UCLA CARE Center, Professor of Medicine and Chief of the Infectious Diseases Division in the Department of Medicine of UCLA DGSOM. She is Co-Director of the AIDS Clinical Trial Group (ACTG) network, having contributed since 1990 to the development, implementation and analysis of clinical research studies in the ACTG. Dr. Currier collaborated in the formation of the Fiocruz ACTG site in Rio de Janeiro, and continues to serve as a mentor to the site’s staff and investigators. She was co-Chair of two international ACTG trials, A5208, evaluating the impact of prior exposure to single dose nevirapine on response to ARV therapy in women, and A5190, evaluating the outcomes of children exposed in utero to antiretroviral therapy during clinical trials. Dr. Currier holds a K24 grant for mentoring Faculty and Fellows at UCLA and Fiocruz. Her research focuses on metabolic outcomes of antiretroviral therapy, including gender-specific responses to treatment, and optimization of antiretroviral therapy, including studies of ARV regimens in international settings.